Aditya Vanarase
About Aditya Vanarase
Aditya Vanarase is a Senior Principal Scientist at Bristol Myers Squibb with extensive experience in the pharmaceutical industry and a strong background in chemical engineering.
Current Role as Senior Principal Scientist at Bristol Myers Squibb
Aditya Vanarase is currently a Senior Principal Scientist at Bristol Myers Squibb. In this role, he applies his extensive expertise in chemical engineering to drive pharmaceutical research and development projects. His responsibilities likely include leading scientific teams, managing complex projects, and contributing to innovative drug development processes.
Past Experience at Bristol Myers Squibb
Aditya Vanarase has had a long tenure with Bristol Myers Squibb, previously serving as Principal Scientist and Senior Engineer from 2019 to 2021. His earlier roles from 2011 to 2016 included Senior Research Investigator and Research Investigator I & II. His work during these periods involved significant contributions to pharmaceutical research in New Brunswick, NJ.
Experience at Celgene
From 2016 to 2019, Aditya worked at Celgene in Summit, NJ. He held titles such as Senior Engineer and Engineer II. In these capacities, he was involved in the engineering aspects of pharmaceutical production, contributing three years of valuable experience to his professional portfolio.
Internships in Chemical Engineering
Earlier in his career, Aditya gained practical industry experience through internships. He spent two months at Abbott Laboratories as a Research Intern in 2009 and another two months at GHARDA CHEMICALS LIMITED in Mumbai, India, in 2005. These internships provided foundational experience and insights into chemical processes and pharmaceutical development.
Educational Background in Chemical Engineering
Aditya Vanarase holds a Ph.D. in Chemical Engineering from Rutgers, The State University of New Jersey-New Brunswick, where he studied from 2006 to 2011. He also earned a B. Chem from the University of Mumbai Institute of Chemical Technology (UICT), studying from 2002 to 2006. His academic background laid the groundwork for his extensive career in pharmaceutical research and development.